We are live on ! Find out more
AHL

Abel Hall LLC Portfolio holdings

AUM $579M
1-Year Est. Return 54.21%
This Fund
S&P 500
This Quarter Est. Return
+11.41%
1 Year Est. Return
+54.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$134M
AUM Growth
+$16.5M
Cap. Flow
+$5.81M
Cap. Flow %
4.35%
Top 10 Hldgs %
55.68%
Holding
159
New
37
Increased
75
Reduced
26
Closed
10

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$353K
2
BA icon
Boeing
BA
+$338K
3
PRU icon
Prudential Financial
PRU
+$333K
4
GIFI
Gulf Island Fabrication
GIFI
+$295K
5
AAPL icon
Apple
AAPL
+$283K

Sector Composition

Rank Sector Weight
1 Technology 10.01%
2 Healthcare 5.06%
3 Financials 4.41%
4 Energy 3.27%
5 Communication Services 3.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
26
Berkshire Hathaway Class B
BRK.B
$1.11T
$821K 0.61%
1,953
+48
+3% +$18.9K
GOOGL icon
27
Alphabet (Google) Class A
GOOGL
$4.08T
$814K 0.61%
5,392
-104
-2% -$14.9K
ETN icon
28
Eaton
ETN
$150B
$797K 0.6%
2,549
+7
+0.3% +$1.91K
LLY icon
29
Eli Lilly
LLY
$1.09T
$772K 0.58%
993
+78
+9% +$55.5K
GOOG icon
30
Alphabet (Google) Class C
GOOG
$4.07T
$758K 0.57%
4,976
-150
-3% -$21.7K
JPM icon
31
JPMorgan Chase
JPM
$950B
$703K 0.53%
3,509
+179
+5% +$32.3K
NVO
32
Novo Nordisk
NVO
$225B
$675K 0.51%
5,257
+212
+4% +$25.2K
MRK icon
33
Merck
MRK
$326B
$673K 0.5%
5,099
+87
+2% +$10.7K
WFC icon
34
Wells Fargo
WFC
$263B
$626K 0.47%
10,806
+326
+3% +$17.1K
CVX icon
35
Chevron
CVX
$374B
$618K 0.46%
3,916
+1,163
+42% +$175K
GSK icon
36
GSK
GSK
$108B
$564K 0.42%
13,156
+107
+0.8% +$4.41K
ASML icon
37
ASML
ASML
$608B
$557K 0.42%
574
+20
+4% +$17.7K
BMY icon
38
Bristol-Myers Squibb
BMY
$130B
$534K 0.4%
9,847
+5,571
+130% +$284K
TTE icon
39
TotalEnergies
TTE
$187B
$521K 0.39%
7,570
-2
-0% -$131
SNY icon
40
Sanofi
SNY
$109B
$514K 0.38%
10,581
-351
-3% -$17.1K
GILD icon
41
Gilead Sciences
GILD
$167B
$497K 0.37%
6,782
+1,940
+40% +$149K
QCOM icon
42
Qualcomm
QCOM
$172B
$491K 0.37%
2,898
+110
+4% +$17K
REET icon
43
iShares Global REIT ETF
REET
$5.18B
$484K 0.36%
20,418
+60
+0.3% +$1.4K
SO icon
44
Southern Company
SO
$109B
$473K 0.35%
6,595
+137
+2% +$9.46K
KO icon
45
Coca-Cola
KO
$380B
$466K 0.35%
7,621
+282
+4% +$16.9K
UNH icon
46
UnitedHealth
UNH
$389B
$465K 0.35%
941
+14
+2% +$7.12K
FNDE icon
47
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.51B
$461K 0.34%
16,599
-1,581
-9% -$42.7K
MA icon
48
Mastercard
MA
$497B
$453K 0.34%
940
+26
+3% +$11.9K
LYB icon
49
LyondellBasell Industries
LYB
$18.8B
$448K 0.34%
4,381
-1
-0% -$97
V icon
50
Visa
V
$697B
$448K 0.33%
1,604
+25
+2% +$6.9K

Similar funds

Abel Hall LLC's Q1 2024 Portfolio in Review

As of Q1 2024, Abel Hall LLC held 159 positions worth $134M, up 14% from $117M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Abel Hall LLC deployed $5.81M of net new capital in Q1 2024, opening 37 new positions and adding to 75 existing holdings. Its largest new stake was Franklin Resources: 11,192 shares worth $315K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $353K trimmed.

  • Abel Hall LLC's largest Q1 2024 buy was Franklin Resources: 11,192 shares worth $315K.
  • Abel Hall LLC added most to Dimensional US Core Equity 2 ETF in Q1 2024, an estimated $800K increase.
  • Abel Hall LLC's biggest Q1 2024 reduction was AbbVie, cutting an estimated $353K.
  • Abel Hall LLC fully exited Boeing in Q1 2024, selling an estimated $338K.
  • Abel Hall LLC's ten largest holdings make up 56% of its $134M portfolio in Q1 2024.
  • Abel Hall LLC opened 37 new positions and closed 10 in Q1 2024.
  • Abel Hall LLC's portfolio value rose 14% quarter-over-quarter to $134M.

Based on Abel Hall LLC's 13F filing for Q1 2024, filed 8 May 2024.